A Multidimensional approach to Severe Asthma Management: the need for Pulmonary Rehabilitation among candidates for Biologic Therapy
Frontiers in Medicine · 23.07.2026 · 13
DOI: 10.3389/fmed.2026.1853986 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Medicine, online erschienen am 23.07.2026. Verfasst von Michela Pozza und 2 weiteren Autor:innen. Beteiligte Einrichtung: Respiratory Pathophysiology Unit, Department of Cardiac-Thoracic-Vascular Sciences and Public Health University of Padova, Padova, Italy. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Despite optimized pharmacological therapy, a significant subset of severe asthma patients remains poorly controlled. Lack of control is often driven by complex, non-inflammatory “treatable traits” that require a multidimensional management strategy beyond traditional airway targeting.
Objective
To characterize clinical, functional, and inflammatory profile of severe asthma patients at the time of prescribing biologic therapy and identify potential candidates to ARM (Assessment-Rehabilitate-Maintenance) pulmonary rehabilitation (PR) program.
Methods
This retrospective study analyzed 195 consecutive adults meeting GINA criteria for severe asthma admitted to our outpatient clinic between January 1, 2015, and December 31, 2025. ARM-program candidacy was predefined by the coexistence of: FEV1 < 80% predicted, mMRC ≥ 2, ACT < 20, and ≥2 annual exacerbations.
Results
The median age of the cohort was 55 years and 60% of patients were female. A substantial disease burden was detected (median ACT: 16; annual exacerbations: 3). Females showed significantly higher maintenance oral corticosteroid (OCS) dependence (35.9% vs. 21.8%, p = 0.036) and increased risk of air trapping (RV/TLC: 42.0% vs. 38.5%, p = 0.035). 47 patients (24%) met ARM candidacy criteria, showing higher OCS use (42.6% vs. 26.4%; p = 0.035), and a four-fold higher prevalence of anxiety/depression (12.8% vs. 3.4%; p = 0.015) compared with non-candidates.
Conclusions
At the time of biologic prescription, a significant proportion of severe asthma patients present a multidimensional burden, including dyspnea, frequent exacerbations, and psychological comorbidities and are potential candidates to ARM PR program. Prospective studies are needed to validate patient selection criteria and support whether pulmonary rehabilitation—may improve clinical and functional outcomes in target subgroup.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Respiratory Pathophysiology Unit, Department of Cardiac-Thoracic-Vascular Sciences and Public Health University of Padova, Padova, Italy.
Zitieren
APA
Pozza, M., Guarnieri, G., & Vianello, A. (2026). A Multidimensional approach to Severe Asthma Management: the need for Pulmonary Rehabilitation among candidates for Biologic Therapy. Frontiers in Medicine, 13. https://doi.org/10.3389/fmed.2026.1853986
Vancouver
Pozza M, Guarnieri G, Vianello A. A Multidimensional approach to Severe Asthma Management: the need for Pulmonary Rehabilitation among candidates for Biologic Therapy. Frontiers in Medicine. 2026;13. doi:10.3389/fmed.2026.1853986
BibTeX
@article{Pozza2026,
author = {Pozza, Michela and Guarnieri, Gabriella and Vianello, Andrea},
title = {A Multidimensional approach to Severe Asthma Management: the need for Pulmonary Rehabilitation among candidates for Biologic Therapy},
journal = {Frontiers in Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fmed.2026.1853986}
}
EUVIMED